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ABSTRACT
Extensive oligodendrocyte death after acute traumatic spinal cord injuries (TSCI) leads to axon 
demyelination and subsequently may leave axons vulnerable to degeneration. Despite the 
present evidence showing spontaneous remyelination after TSCI the cellular origin of new 
myelin and the time course of the axon ensheatment/remyelination remained controversial 
issue. In this systematic review the trend of oligodendrocyte death after injury as well as the 
extent and the cellular origin of oligodendrogliogenesis were comprehensively evaluated. The 
study design was based on Preferred Reporting Items for Systematic Reviews and Meta-
Analysis (PRISMA)-guided systematic review. PubMed and EMBASE were searched with no 
temporal or linguistic restrictions. Also, hand-search was performed in the bibliographies of 
relevant articles. Non-interventional animal studies discussing different types of myelinating 
cells including oligodendrocytes, Schwann cells and oligodendrocyte progenitor cells (OPCs) 
were evaluated. The extent of oligodendrocyte death, oligodendrocyte differentiation and 
remyelination were the pathophysiological outcome measures. We found 12,359 studies, 34 of 
which met the inclusion criteria. The cumulative evidence shows extensive oligodendrocytes 
cell death during the first week post-injury (pi). OPCs and peripheral invading Schwann cells 
are the dominant cells contributing in myelin formation. The maximum OPCs proliferation was 
observed at around 2 weeks pi and oligodendrogliogenesis continues at later stages until the 
number of oligodendrocytes return to normal tissue by one month pi. Taken together, the 
evidence in animals reveals the potential role for endogenous myelinating cells in the axon 
ensheathment/remyelination after TSCI and this can be the target of pharmacotherapy to induce 
oligodendrocyte differentiation and myelin formation post-injury.
Keywords: Spinal cord injury; Myelin; Oligodendrocytes; Schwann cells; Progenitors; 
Oligodendrogliogenesis
INTRODUCTION
Traumatic spinal cord injury (TSCI) is a devastating event involving approximately between 
3.6 and 195.4 cases per million annually in different countries (Jazayeri et al., 2015). The acute 
trauma initiate a cascade of progressive events which last by one year after injury and cause 
secondary injury (Rowland et al., 2008). Based on different degenerative events during the 
secondary injury various regenerative and repair strategies have been proposed and are under 
development to induce axon regeneration and remyelination which can be categorize in 3 
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different classes: cell-based strategies (Keirstead et al., 2005, Priest et al., 2015), drug therapies 
(Nagoshi et al., 2015) and tissue engineering approaches (Piantino et al., 2006, Fuhrmann et 
al., 2016). In some cases the outcomes of animal studies have provided the rationale for clinical 
trials (clinicaltrials.gov). Although many studies propose the advantageous of acute 
intervention in order to restrict the progress of secondary events (Fehlings et al., 2016), the 
endogenous regenerative responses at later times post-injury may also provide some extra 
therapeutic opportunities.
Oligodendrocytes are myelinating cells residing in central nervous system (CNS). During 
development oligodendrocytes are mostly derived from neuroepithelial zones, where 
neuroepithelial stem cells (i.e. stem cells of the nervous system) differentiate into 
oligodendrocyte precursor cells (OPCs). Subsequently, OPCs differentiate into pre-
myelinating oligodendrocytes and finally into mature myelinating oligodendrocytes (van 
Tilborg et al., 2018). Myelination is a dynamic and plastic process with an excess of OPCs 
being generated and remained throughout adulthood which are recruited to drive remyelination 
in case of injury or neurodegenerative diseases (Gautier et al., 2015). 
After SCI oligodendrocyte death leads to axon demyelination and leave axons vulnerable to 
degeneration (Hill et al., 2001, Houle and Jin, 2001, Hassannejad et al., 2018). Spontaneous 
remyelination after injury has been revealed in some studies (Bartholdi and Schwab, 1998, 
Horky et al., 2006, McDonough et al., 2013, Hesp et al., 2015, Assinck et al., 2017). Mature 
oligodendrocyte, OPCs as well as Schwann cells (i.e. peripheral resident myelinating cells) 
have been introduced as the cells contributing in remyelination after SCI. It has been shown 
that after injury OPCs and Schwann cells that are quiescent in normal conditions become 
activated, develop a larger cytoplasm and thinner cell processes. They proliferate and recruited 
to the injury site to restore the damage caused by dying oligodendrocytes through expression 
of neurotrophic factors to establish a growth promoting environment and enwrapping neuronal 
axons to remyelinate nude axons (for excellent review, see de Castro et al. (2013)). 
The extent of oligodendrocyte death, endogenous remyelination and contribution of each of 
the aforementioned cells in myelin formation have been evaluated separately in different time 
points from immediate to chronic phases. However, the spatial and temporal pattern of myelin 
formation as well as prominent cell type contributing in axon ensheathment/remyelination in 
each time point or various regions of cord have not yet fully addressed. In this study the fate 
of mature oligodendrocytes and their proliferative potential after injury, cell sources to 
compensate the extensive loss of oligodendrocyte and also the extent of remyelination after 
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injury have been systematically evaluated in order to reveal the appropriate time points to 
augment spontaneous remyelination. Based on the present evidence myelinating cells respond 
to TSCI in a way that after initial loss the number of oligodendrocytes approaches to the normal 
levels after about one month post-injury. The majority of oligodendrocytes are lost at the 
epicentre and adjacent regions, however, OPCs proliferation and subsequent differentiation to 
myelinating cells (both oligodendrocytes and Schwan cells) are the main route to compensate 
the extensive demyelination after injury. Invading peripheral Schwann cells also contribute in 
remyelination. Taken together, the evidence in animals suggests an important potential role for 
endogenous myelinating cells in the axon ensheathment/remyelination after TSCI. 
METHODS
Search and Selection of Studies
We searched Embased and MEDLINE via Ovid SP on 9 November 2013 and we updated this 
search on 24 October 2015 and 7 September 2018. Keywords were determined based on 
research team discussion, experts’ opinion, literature reviews, controlled vocabulary (Medical 
Subject Headings = MeSH and ExcerptaMedica Tree = EMTREE) and review of the records 
retrieved in the initial search. The search strategy was then developed with assistance of a 
medical information specialist. The following keywords and MeSH terms were used: “Spinal 
cord injury”, “trauma”, “cell”, and “pathophysiology” Search results were exported into 
EndNote X5. Also, a detailed review of the reference lists of the most relevant publications 
was performed. 
Eligibility Criteria
All the articles investigating the pathophysiology of TSCI in animal after acute traumatic 
mechanical spinal cord injury including compression, contusion, hemisection and transection 
were included. Publications that did not specify cell type, and exact time points for the 
pathophysiological events were not included. In addition, in order to increase the homogeneity 
of included studies, we excluded studies reporting on humans (i.e. all clinical studies and case 
reports), non-mechanical injuries, including thermal and ischemic injuries and other 
interventions. Finally, non-original articles, including review articles and letters were 
excluded. No restrictions in regard to period of publication and language were applied. 
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Selection Process
Two authors independently assessed each article based on the title, abstract and finally the full-
text (ASM & MM, SA & ZH). In a case of disagreement, a third independent person (VRM) 
assessed the article and the final decision was made accordingly. 
Outcome Measures
Different types of myelinating cells including oligodendrocytes, Schwann cells and OPCs, 
which are believed to be committed to oligodendrocyte lineage, were evaluated. Cell death, 
differentiation and proliferation rates for the aforementioned cell types were the 
pathophysiological outcome measures.  
Data Extraction and Quality Assessment
Data were extracted to a data extraction form developed in our group by two independent 
members. On this form, general information about each article including the title, authors’ 
name, publication date, information about method including study design (type/severity/level 
of injury), time of assessments, animal number and animal characteristics (strain, sex, age or 
weight), method(s) of evaluation and finally the research question and relevant results were 
recorded. 
 In order to control the quality of the included articles, two independent reviewers evaluated 
each article according to the criteria for TSCI (Hassannejad et al., 2016). Briefly, the quality 
of each article was assessed based on 15 items including: 1. species; 2. using appropriate tests; 
3. severity of injury; 4. level of injury; 5. age/weight; 6. number of animals per group; 7. 
designation of strain; 8. definition of control; 9. description of statistical analysis; 10. bladder 
expression; 11. genetic background; 12. method of allocation to treatments; 13. description of 
the reasons to exclude animals from the experiment during the study (attrition); 14. blindness 
of assessors of the original investigators; 15. regulations and ethics
RESULTS
Description of the Included Studies
The search yielded to 12,359  records. After screening the articles, 520 articles were included 
for the full-text review. A final 34 articles were included for outcome evaluation. The search 
flowchart and selection methods are presented in Fig. 1. Furthermore, characteristics of the 
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included studies are presented in Table 1. The quality assessment of 34 included studies was 
then assessed and the results are presented in the Table 2.
Figure 1
Table 1
Table 2
Oligodendrocytes and oligodendrocyte progenitor cells
There were 29 studies discussing the fate of oligodendrocytes as well as OPCs after TSCI 
(Griffiths and McCulloch, 1983, Blight, 1985, Shuman et al., 1997, Bartholdi and Schwab, 
1998, Salgado-Ceballos et al., 1998, Yong et al., 1998, Abe et al., 1999, Li et al., 1999, Frei et 
al., 2000, Casha et al., 2001, Grossman et al., 2001, McTigue et al., 2001, Warden et al., 2001, 
Dong et al., 2003, Wu et al., 2005, Zai and Wrathall, 2005, Horky et al., 2006, Yang et al., 
2006, Lytle and Wrathall, 2007, Rabchevsky et al., 2007, Tripathi and McTigue, 2007, Ceruti 
et al., 2009, Sellers et al., 2009, Wang et al., 2009, Barnabe-Heider et al., 2010, McDonough 
et al., 2013, Huang et al., 2014, Hesp et al., 2015, Assinck et al., 2017). 
A total of 287 CreER transgenic mice (2 studies), 135 Swiss Webster mice (one study), 56 
mice (species not available, 2 studies), 299 Sprague-Dawley rats (6 studies), 365 Fischer rats 
(2 studies), 28 Long-Evans rats (one study), 62 Lewis rats (2 studies), 32 rats (species not 
available, one studies), 26 mongrel cats (one study) and 5 Rhesus  monkeys (one study) 
underwent TSCI. Also, the number of animals was not mentioned in 11 studies: C57BL6 mice 
(one study), CD1 mice (one study), Wistar rats (2 studies), Sprague-Dawley rats (3 studies), 
Fisher rat (one study), cat (species not specified, one study), rat (species not specified, one 
study) and mice (species not specified, one study). 
The collected data included the results of immunohistochemistry, light and electron 
microscopy and flow cytometry. The markers and methods used to identify the cell types (i.e., 
oligodendrocytes and OPCs) and to detect apoptosis are summarized in Table 3.
Table 3
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The extent of oligodendrocytes death at the lesion center and adjacent regions after TSCI
The earliest evaluated time point was 15 minutes pi, when the number of oligodendrocytes 
(CC1+) signiﬁcantly decreased at the epicenter as well as 2 mm caudal and rostral to the injury 
site (Grossman et al., 2001). Reduction in the number of oligodendrocytes persisted ±3 mm 
away from the lesion site, however, it was not statistically significant comparing to the 
uninjured tissue at this time point (Grossman et al., 2001). By one hour pi, no noticeable 
changes were observed 3 to 10 mm rostral and caudal to the lesion epicentre (Wang et al., 
2009).
Four hours pi, a further 50% of oligodendrocytes were lost at the epicenter (Grossman et al., 
2001) and according to Li et al. (1999) a small, statistically non-significant portion of this 
reduction was due to apoptosis. At 6 hours pi, TUNEL+ cells were detected at the epicenter and 
1-2 mm distal to the injury, most of them displaying oligodendrocyte characteristics (double-
labelled with CNPase) (Casha et al., 2001, Grossman et al., 2001). Eight and 24 hours pi, a 
persistent significant reduction in the number of oligodendrocytes was seen at distances up to 
2 mm rostral and caudal to lesion epicenter (Bartholdi and Schwab, 1998, Grossman et al., 
2001).
At 24 hours pi, the number of apoptotic oligodendrocytes (TUNEL/CNPase+) at the white 
matter (WM) of epicenter approximately doubled compared to controls (Huang et al., 2014). 
Also, in spared WM at the epicenter, the density of mature oligodendrocytes decreased 
signiﬁcantly by 24 hours pi (Lytle and Wrathall, 2007). At this time point, 1.5 mm rostral and 
caudal to the injury site, as well as epicenter, CC1+ oligodendrocytes were significantly reduced 
(Lytle and Wrathall, 2007). Accordingly, 24 hours pi PLP (proteolipid protein) mRNA 
expression was mostly absent in the central necrotic area which indicated a significant loss of 
oligodendrocytes in this area (Frei et al., 2000). Li et al. (1999) reported, using TUNEL assay, 
a statistically non-significant presence of apoptotic cells rostral (T1-T7) and caudal (T10-L2) 
(where the epicenter was T8-9) 24 hour pi after moderate and severe injuries (Li et al., 1999).
At 2 days pi, the total number of mature oligodendrocytes (CC1+) decreased to less than half 
of the naïve animals at the epicenter and ventral-lateral funiculi up to 14 mm distal to the 
injury site (Rabchevsky et al., 2007).
At day 3, the number of apoptotic oligodendrocytes (TUNEL/CNPase+) was higher than day 
1 as well as control animals, at the epicenter (Huang et al., 2014) and within 4 mm distal to 
the epicenter (Yong et al., 1998). From the third day, TUNEL-MBP+ (Myelin basic protein) 
cells were found sparsely scattered in the WM remote from the epicenter (Abe et al., 1999). 
It is likely that from the third day onwards, the zone of apoptotic oligodendrocytes spread 
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to sites remote from the epicenter. At 4 days pi, the number of apoptotic cells significantly 
decreased in caudal (T12, and L2 where the injury is applied at T8-9) and rostral segments (T1, 
T5, and T7) in moderate and severe compression (Li et al., 1999). The labelled cells were 
randomly distributed in the ventral, lateral and dorsal columns of the WM; most of them were 
located in the subpial region. However, very few labelled cells were found in grey matter (GM) 
(Li et al., 1999). The mentioned trend of oligodendrocytes apoptotic death is represented in 
Fig. 2. 
Figure 2
At 7 days pi, the number of CC1+ cells reduced significantly in all zones up to 14 mm distal 
to the injury compared to control animals (Rabchevsky et al., 2007). Also, in ventrolateral 
WM, the density of mature oligodendrocytes was less than 50% of that in normal uninjured 
mice (Lytle and Wrathall, 2007). In epicenter cross-sections, the proportion of 
oligodendrocytes to all survived cell types was reduced from 93% to %86 cells per section. 
Indeed, most oligodendrocytes in the impact site died within the first week after injury 
(McTigue et al., 2001). In another study, cell counts in the dorsal fasciculus above the lesion, 
as well as lateral tracts above and below the lesion, showed that TUNEL+ cells (presumably 
oligodendrocytes, because they were negative for GFAP, neurofilament, OX-6 and BS-1 
markers) first appeared by 3 days pi, becoming maximal in number between days 5 and 7 
(Abe et al., 1999). Also, two other studies confirmed that 7 days pi was the time point when 
the number of apoptotic oligodendrocytes reached the maximum (Casha et al., 2001, Huang 
et al., 2014).
At 8 days pi, apoptotic oligodendrocytes were most numerous in 7 and 13 mm rostral to the 
epicenter (Shuman et al., 1997). Also, eight days after T9 level hemisection in C57BL/6J mice, 
a selective loss of oligodendrocytes were observed 3-7 mm rostral and caudal to epicenter. 
Staining for CC1 and caspase-3 (a protein that is associated with apoptosis) confirmed 
activated caspase-3 was expressed in oligodendrocytes on injured side of this area but neither 
in the intact side of the cord nor in control sections. From double-labelling of CC1 and caspase-
3, it was also concluded that approximately 10–15% of oligodendrocytes in this region 
expressed both epitopes. At this time point in the areas up to 5 mm from the epicenter, a 
significant loss of oligodendrocytes was observed on the injured side. Moreover, ultrastructural 
examination at 5-7 mm away from the epicenter showed prominent apoptotic features (Dong 
et al., 2003). In transection models from day 2 to 8, in situ hybridization revealed that a large 
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area surrounding the epicenter was completely free from MBP mRNA, indicating complete 
loss of oligodendrocytes within this zone (Bartholdi and Schwab 1998).
By 9 dpi, a significant increase in the number of apoptotic oligodendrocyte was seen in rostral 
(T1 to T7) and caudal segments (T10, T12, and L2) (Li et al., 1999). 
The number of apoptotic oligodendrocytes varied between moderate and severe injuries. After 
moderate injury the highest number of apoptotic cell death occurred in T7 and T10 segments 
while in severe injury the lesion size extended and the highest number of apoptosis observed 
in the T7 and T12 segments. In all examined segments there were more apoptotic 
oligodendrocytes in severely than in moderately injured rats. However, the difference was not 
statistically significant (Li et al., 1999).
By 10 days pi, oligodendrocytes were still present in areas with degenerating axons, Wallerian 
degeneration (WD) zone (i.e., 3 to 10 mm caudal and rostral to injury epicenter). However, the 
number of oligodendrocytes was significantly reduced to less than half of oligodendrocytes in 
sham operated animals (number of Olig2+ cells: ~ 60, 50, and 100 in dorsal ascending tracs, 
corticospinal tract and sham, respectively) (Wang et al., 2009).
In the second week after injury, the number of apoptotic oligodendrocytes declined 
significantly in lateral tracts above and below the injury site and the dorsal column (Abe et al., 
1999), but they were still present 1-2 mm distal to the epicenter (Casha et al., 2001). The 
epicenter itself was already devoid of oligodendrocytes; only an amorphous mass of cell debris 
and MBP-positive macrophages were observed at the lesion epicenter, where MBP mRNA was 
almost absent. The very few MBP mRNA expressing cells detected in the dorsal funiculi that 
were probably due to invading Schwann cells (Bartholdi and Schwab 1998). 
The oligodendrocyte processes formed a deﬁned border separating the lesion area from the 
spared tissue (Bartholdi and Schwab 1998). In WM areas remote from the lesion, signs of WD 
became very prominent; at the center of the degeneration zone MBP mRNA+ oligodendrocytes 
were lost; however, levels of MBP mRNAs strongly increased at the borders of the lesion 
(Bartholdi and Schwab, 1998). 
Yong et al. also detected a second peak of oligodendrocyte apoptosis at 14 days pi (Yong et 
al., 1998). Since, at this time point the authors did not specify the areas where the TUNEL/RIP+ 
cells were present, this second peak could be due to death in the WD zones rather than the 
epicenter where the first peak of apoptotic oligodendrocytes was observed at 5-7 days pi.
Apoptotic cell death of oligodendrocytes continued by the third weeks pi (Crowe et al., 1997, 
Shuman et al., 1997). At this time point, oligodendrocytes apoptosis had decreased slightly in 
rostral blocks, in contrast to 7 mm caudal to the lesion epicenter where apoptosis increased 
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(Shuman et al., 1997). Between 8 and 30 days pi, a delayed apoptosis of oligodendrocytes 
continued specifically in distal zones both rostral and caudal (Dong et al., 2003).
By the fourth week after injury, in WM at the epicenter, the density of apoptotic 
oligodendrocytes reduced to the normal level (Lytle and Wrathall, 2007); also at 1.5 mm rostral 
and caudal to the injury epicenter in two injured mice the density of oligodendrocytes returned 
to the levels of uninjured controls (Lytle and Wrathall, 2007). Thus by the fourth week, the 
number of oligodendrocytes seemed to stabilize and remain constant thereafter (McTigue et 
al., 2001). The summary of OL’s death is schematically presented in Fig. 2. 
The response of oligodendrocyte progenitor cells to TSCI
At 24 hours pi, the proportion of BrdU/Olig2+ cells dropped dramatically from ~ 90% in control 
to almost 40% at the epicenter (McDonough et al., 2013), which shows that OPCs that were 
proliferating before injury either die or do not activate a proliferation program to a significant 
extent after TSCI (Horky et al., 2006). Meanwhile, a peak of NG2+ cell proliferation was 
observed at the 1.5 mm away from the epicenter (Lytle and Wrathall, 2007), and a small 
increase in number of NG2+ cells at the WM 5 and 10 mm caudal to the epicenter was detected 
(Wu et al., 2005). The NG2+ cells as well as newly formed oligodendrocytes were surrounding 
lesion borders (Hesp et al., 2015).
At day 2 pi, the number of NG2+ cells were increased by 50% compared to controls at the distal 
ventrolateral funiculi but did not change at the epicenter (Rabchevsky et al., 2007). One to 
three days pi, the number of proliferating OPCs (BrdU/NG2+ cells) in spared WM increased 
slightly but insignificantly compared to control animals (25 and ~10 cells/mm2, respectively), 
whereas in GM (borders and spared GM), the number was significantly higher (>40 cells/mm2). 
Most of the NG2+ cells proliferated at lesion borders (1-2 mm distal from epicenter) (Lytle and 
Wrathall, 2007, Tripathi and McTigue, 2007), significantly more than control animals (Ceruti 
et al., 2009) while decreasing at the epicenter compared to control (Lytle and Wrathall, 2007). 
In areas 2-4 mm distal to the epicentre, as well as lesion borders, half of the dividing cells were 
NG2+ at day 3 and some of the NG2+ cells were co-labelled with GFAP (marker of astrocytes) 
(Zai and Wrathall, 2005, Ceruti et al., 2009). There were only a few proliferating CC1+ cells 
in the lesion area and WM distal to the epicentre (Ceruti et al., 2009).
Later, during 4-7 days pi, OPCs continued to proliferate at the WM and GM lesion borders and 
some evidence of oligodendrogliogenesis was revealed along the lesion borders (Tripathi and 
McTigue, 2007). At day 7, the total number of NG2+ cells were higher at the spared WM at the 
epicentre compared to control animals (Lytle and Wrathall, 2007). There was small reduction 
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in NG2+ cells compared to day 2 (Rabchevsky et al., 2007), yet remained 8 times higher than 
control animal, comprising over 80% of the proliferating cells at the lesion borders (Ceruti et 
al., 2009). At the ventrolateral funiculi, an increase in total number of mature oligodendrocytes 
was observed (Rabchevsky et al., 2007). In another study, the number of proliferating NG2+ 
cells (BrdU/NG2) were reported to increase up to three times within the epicentre (both at the 
spared and lesion areas) and up to 6 times rostral and caudal to the epicentre (< 2 mm) 
(McTigue et al., 2001).
At the first week pi, in 5 mm caudal from the epicentre, an increased number of NG2+ cells 
was observed in WM. Also, NG2+ cells in the WM from subpial region 5 mm distal to the 
epicentre were predominantly co-labelled with GFAP (Wu et al., 2005).
The OPCs that had proliferated during the first week, kept proliferating during the second week 
(7-14 dpi) at the GM lesion borders, whereas at the WM lesion borders the number remained 
similar to 7 days pi. The proliferation of OPCs at the borders led to higher numbers of newly 
formed oligodendrocytes in this areas during the first three days ( ~17 cells/mm2) compared to 
control animals (<5 cells/mm2) (Tripathi and McTigue, 2007). In-situ hybridization of MBP 
mRNA at the lesion borders showed an increase in MBP expression in WM and GM at 8 days 
pi. These MBP-expressing cells, displayed the initial signs of remyelination by forming loose 
network of cells at the lesion borders (Bartholdi and Schwab, 1998). At 9 days pi Mcdonough 
et al. reported a decrease in proportion of BrdU+ cells that expressed Olig2 at epicentre and 
regions next to the epicenter, both in WM and GM (McDonough et al., 2013). This could be 
due to the onset of differentiation of OPCs to a committed cell lineage when an upward trend 
is seen in the proportion of oligodendrocytes compared to previous time points (McDonough 
et al., 2013).
By the second week pi a continual trend in the reduction of the extent of NG2+ and Olig2+ cells 
was seen reaching that of normal controls and remaining at this level afterwards (McTigue et 
al., 2001, McDonough et al., 2013). Also, in the regions that OPCs were highly proliferative 
during 1-3 days (i.e. spared WM), the number of oligodendrocytes was doubled compared to 
day 3, indication of the oligodendrogliogenesis process. An excess of oligodendrocytes was 
also observed in spared GM (>40 cells/mm2) where the OPCs proliferated within the first three 
days after injury. As expected, the greatest increase in number of oligodendrocytes was 
detected in the area where OPCs had proliferated i.e. WM and GM lesion borders (>50 
cells/mm2). The highest proliferation rate occurred 1-2 mm distal from the epicentre (Tripathi 
and McTigue, 2007). The new oligodendrocytes formed a border between the lesion epicentre 
and the intact regions (Tripathi and McTigue, 2007). Similarly, it has been reported that the 
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number of oligodendrocytes was significantly increased in areas distant from the injury 
epicentre (> 6 mm), mainly in WM close to the border of the pia-matter (Rabchevsky et al., 
2007, Hesp et al., 2015). By this time, the density of proliferating NG2+ cells was still higher 
at the epicentre and up to 2 mm away from the lesion epicentre (~3.8 and ~4.5-fold, 
respectively) compared to the control animals (McTigue et al., 2001). However, at 4 weeks pi, 
the density of the proliferating NG2+ cells at the epicenter was in the normal level (Horky et 
al., 2006). 
At 4 weeks pi, the total number of NG2+ cells was higher in rostral and caudal spared WM, 
and at the epicentre (~ 76, ~ 63, and ~ 64 cells/mm2) compared to control animals ( ~ 40 
cells/mm2) (Lytle and Wrathall, 2007). This observations validated that NG2+ cells were 
continuously proliferating during the first month while preserving their progeny (Hesp et al., 
2015). 
McTigue et al. reported a decrease in the total number of NG2+ cells at the epicentre and rostral 
to the levels even less than uninjured animals, and a slight decrease compared to week 2 but 
still higher than caudal sections of normal tissue (McTigue et al., 2001). However, these cells 
were still proliferating at higher rates than in controls (~20-25 NG2/BrdU+ cells/section as 
opposed to ~5 cells/section in naïve) (McTigue et al., 2001). Similarly, the proliferation rate 
has been reported to decline after 4 weeks pi, but remaining 3-9 fold higher than control animals 
(Hesp et al., 2015). The highest number of NG2+ cells was observed 5-10 mm rostral and caudal 
to the epicentre (Wu et al., 2005), whereas, at the WM of the epicentre, the number of 
oligodendrocytes returned to normal amount (Lytle and Wrathall, 2007).
At 6 weeks pi, although the number of NG2+ cells was still higher than controls (Rabchevsky 
et al., 2007), a very few proliferating cells were seen distal (2-4 mm) to the epicentre. However, 
one-fourth of the total oligodendrocytes were proliferative in this region, which is presumably 
the result of the NG2+ cells proliferation at the early stages (Zai and Wrathall 2005). The 
number of oligodendrocytes had returned to normal, validating the recovery of oligodendrocyte 
population by this time (Rabchevsky et al., 2007). These newly formed oligodendrocytes ran 
processes along the axons, and initiated remyelination from 6 weeks pi to as late as 9 weeks pi 
(Hesp et al., 2015). The fluctuation in proliferation rate of OPCs in epicenter and distal regions 
has been schematically demonstrated in Fig. 3. 
Figure 3
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Extensive oligodendrogliogenesis occurred during the first 7 weeks after injury leading to the 
recovery of oligodendrocytes (Bartholdi and Schwab, 1998, Horky et al., 2006, Rabchevsky et 
al., 2007, Tripathi and McTigue, 2007, Hesp et al., 2015). As opposed to NG2 expression that 
declined at 8 and 12 weeks pi (Wu et al., 2005) and was rarely detected at weeks 7 and 9 (Yang 
et al., 2006), the number of proliferating oligodendrocytes (BrdU+/APC+ or CC1+) 
continuously increased at 3 (Horky et al., 2006) 7, 9, 15, and 29 weeks pi (Yang et al., 2006). 
The vast majority of new oligodendrocytes at 3-4 months pi, was derived from OPCs (Barnabe-
Heider et al., 2010, Assinck et al., 2017). McTigue et al. reported that the proliferative response 
of OPCs  remains elevated compared to normal animals up to 4 weeks pi, and returns back to 
normal levels at 10 weeks pi (McTigue et al., 2001). In mice, on the other hand, the total 
number of NG2+ cells escalated 4, 5, 6, 7, and 9 weeks pi in both WM and GM compared to 
uninjured control animals (Hesp et al., 2015). This shows a long-term maintenance of the OPCs 
population in both rats and mice and it overall reveals that proliferation of OPCs during the 
first two weeks is the source of newly formed oligodendrocytes and remyelination at later 
times. The oligodendrogliogenesis and total number of oligodendrocytes over time after injury 
outlined in Fig. 4.
Figure 4
OPCs are the main source of new mature oligodendrocytes after TSCI and the reduction in the 
extent of OPCs at chronic phase after injury is a result of oligodendrocyte differentiation. This 
assumption has been confirmed using mapping the fate of OPCs after injury (Assinck et al., 
2017). There was significantly more oligodendrocytes at 12 weeks pi compared with 3 weeks 
pi. Reciprocally, there was lower percentage of recombined OPCs (17%) at 12 weeks pi 
compared with 3 weeks pi (35%) (Assinck et al., 2017).
Schwann Cells
A total of 11 studies reporting data concerning Schwann cells and the comprehensive 
information as specified above were retrieved (Gilson and Stensaas, 1974, Matthews et al., 
1979, Griffiths and McCulloch, 1983, Blight, 1985, Bartholdi and Schwab, 1998, Brook et al., 
1998, Salgado-Ceballos et al., 1998, Yang et al., 2006, Hui et al., 2010, James et al., 2011, 
Assinck et al., 2017). The experimental data of these studies were based on observations in 70 
Sprague-Dawley rats (one study), 87 Lewis rats (two studies), 108 Long-Evan rats (2 studies), 
24 Wistar rat (one study), 233 CreER transgenic mice (one study), 35 cats (2 studies), 30 
zebrafish (one study) and 5 Rhesus  monkeys (one study).
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Reported data were based on immunohistochemistry, light and electron microscopy 
techniques. Also in one study the fate and origin of Schwann cells at the desired time was 
elucidated using the technology of CreER transgenic mice. In the earlier studies the presence 
of Schwann cells in the CNS parenchyma was identified using ultrastructural evaluations, 
Schwann cells produce thicker and more compact sheaths comparing to oligodendrocytes. 
While in the recent articles the expression of the P0 was chosen as the marker of the myelinating 
Schwann cells. A schematic comparison between the morphology and composition of myelin 
generated by Schwann cells in the CNS versus that derived from OPC differentiation is 
depicted in Fig. 5.
Figure 5
Myelin production by Schwann cells is a protracted process, which occurs in moderate to 
severe spinal cord injuries (data were not available for mild injuries). The migration of 
Schwann cells to the spinal cord parenchyma was reported to be limited due to the presence of 
astrocytes (Franklin and Blakemore, 1993). Eventually, in moderate to severe injuries, where 
the supportive cells, particularly astrocytes, suffer considerable damage, Schwann cells can 
migrate to the CNS tissue  (Salgado-Ceballos et al., 1998). The extensive presence of dividing 
Schwann cells suggests that these cells are at least partly responsible for axon 
ensheathment/remyelination after injury (Hui et al., 2010). 
The number of proliferative Schwann cells increases over time after injury. In one study 
evaluating the proliferative potential of P75+ Schwann cells in Rhesus monkeys, a 14-fold 
increase in the number of BrdU positive Schwann cells was detected at 25 weeks compared to 
7 weeks pi, while there was no proliferative Schwann cells in non-injured control (Yang et al., 
2006).
At one week pi, Schwann cells or their precursors appeared caudal to the lesion (0.5-2 mm 
from the epicenter). The precursors were small, undifferentiated cells lacking a basement 
membrane and were in association with sprouts of invading axons near the roots (Gilson and 
Stensaas, 1974, Blight, 1985). Also, bipolar spindle-shaped cells with ovoid nucleus were 
randomly dispersed, which is a typical morphology of migrating Schwann cells (Brook et al., 
1998). In zebrafish, division of Schwann cells was observed at day 10 after injury which 
probably is the onset for ensheathment/remyelination (Hui et al., 2010).
At the second week pi, the presence of Schwann cells were also detected in the dorsal funiculi 
(Bartholdi and Schwab, 1998), they possessed basement membrane, elongated nucleus and 
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were closely associated with individual axons (Gilson and Stensaas, 1974, Matthews et al., 
1979). 
By the third week, groups of axons myelinated by Schwann cells were frequent around the 
cystic cavity and base of the dorsal columns (Griffiths and McCulloch, 1983). Up to one month 
pi, many unmyelinated fibers were enveloped by Schwann cells, either isolated or in small 
clusters (Salgado-Ceballos et al., 1998). In addition, many axons appeared to be remyelinated 
by Schwann cells (Hui et al., 2010, James et al., 2011).
Six weeks pi, at the dorsal column, there were fascicles with thin perineural sheath containing 
up to 50 axons and restricted to immediate regions of the lesion site (Matthews et al., 1979). 
By two months pi, many of myelinated axons had grown toward the scar matrix. Those in 
dorsal region were apparently myelinated by Schwann cells (Matthews et al., 1979, Salgado-
Ceballos et al., 1998). At this time, approximately one third of the fibers were myelinated and 
the ratio of myelinated axons by Schwann cells to oligodendrocytes was about 8:1 (Salgado-
Ceballos et al., 1998). It is worth noting that in this report the authors assume that thick myelin 
sheaths are associated with Schwann cells. 
As the injury progressed into chronic stages (3 and 4 months), many axons had dense, healthy 
myelin sheaths and it was often associated with the presence of Schwann cells  (Salgado-
Ceballos et al., 1998, James et al., 2011). The Schwann cells contribution in remyelination of 
the axons in dorsal column was also confirmed by co-staining of axons (NF 200) and Schwann 
cell-associated myelin (P0) (James et al., 2011). In this study P0 reactivity was detected at 4 
and 12 weeks but not one week pi. Remyelination by Schwann cells continued by 12 months 
pi (Salgado-Ceballos et al., 1998). 
Although the Schwann cells contribution in remyelination after SCI is a well-shown evidence, 
the origin of the present Schwann cells in the CNS parenchyma is still a contentious issue. In 
a recent study at 12 weeks pi fate mapping experiments revealed that the most majority of 
Schwann cells (about 70-80%) which contribute in myelin production after TSCI were derived 
from Olig2+ and PDGFRα+ CNS OPCs rather than P0 expressing peripheral myelinating 
Schwann cells (Assinck et al., 2017). OPC-derived myelinating Schwann cells were mainly 
found in the dorsal column (Assinck et al., 2017).
DISCUSSION
Extensive oligodendrocytes cell death during the first two weeks after injury leave a broad 
number of denuded axons in the epicenter as well as distal regions. Oligodendrocyte cell death 
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occurs through both mechanisms of apoptosis and necrosis while apoptosis was initially 
detected in epicenter and was extended rostro-caudally. 
Along with the mature oligodendrocytes, many OPCs are lost at early stages, however, as early 
as one day pi they start proliferation at the lesion borders and spared tissues. Later, 
differentiation of these newly formed OPCs compensate the lack of oligodendrocytes. 
Oligodendrogliogenesis continues at later stages until the number of oligodendrocytes return 
to normal (by one month pi). Despite differences between animals after TSCI, the glial 
response to injury and in particular myelinating cells shares similarities.
Recently numerous studies in the field of spinal cord regeneration has been focused on 
oligodendrocyte protection and enhancing remyelination after TSCI. Demyelination is a part 
of secondary injury cascade which initiate immediately after injury. The present preclinical 
evidence reveals the potential of remyelination in adult tissue. Remyelination of spared and 
growing axons occurs through a two-step process: 1. providing a sufficient population of 
myelinating cells and 2. induction of remyelination. 
Therefore, a key determinant of the success of remyelination after injury is the proliferative 
ability of myelinating cells. In this study according to the included articles it can be concluded 
that oligodendrocytes within a demyelinated region of spinal cord are not induced to divide in 
the presence of demyelinated axons and the survived oligodendrocytes are post-mitotic and do 
not contribute to the remyelination in adult CNS. However, it should be noted that the 
oligodendrocyte proliferation after TSCI was not fully refute and there are some studies 
discussing the proliferative ability of oligodendrocytes within a demyelinated region of spinal 
cord (Vick et al., 1992). According to the fact that the Schwann cells and OPCs proliferation 
after injury is a prerequisite to remyelination, the finite proliferative potential of 
oligodendrocytes after injury may be the cause of low contribution of mature oligodendrocytes 
in remyelination.
OPCs constitute the dominating proliferating cell population in the intact adult spinal cord 
(Horky et al., 2006, Sellers et al., 2009, Barnabe-Heider et al., 2010). Indeed, according to 
accumulating evidence in this study spinal cord injury results in changing the proliferation rate 
of OPCs over time and within the first two weeks the proliferation rate of OPCs reaches to a 
maximum at both regions of epicenter and lesion border  (Fig. 3). Reduction in the proliferation 
is followed by the oligodendrocyte differentiation, as demonstrated by detection of an elevated 
number of oligodendrocytes one week after injury which reaches to the normal level by about 
one month pi. Endogenous remyelination after TSCI was also confirmed by detection of an 
increase in the expression of MBP at first week pi compared to earlier days (Bartholdi and 
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Schwab, 1998, Horky et al., 2006, McDonough et al., 2013, Hesp et al., 2015, Assinck et al., 
2017). However, Assinck et al. through fate mapping of the OPCs showed that although there 
was a significant increase in the extent of new myelin from 3 to 12 weeks pi, the total myelin 
did not demonstrate a significant change and they attribute this to the myelin turn over and 
replacement between 3 and 12 weeks pi (Assinck et al., 2017). 
Schwann cells that normally reside in peripheral nervous system, participate in remyelination 
of the denuded axons within the cord through a protracted process. Abundant preclinical 
(Martin et al., 1996, Oudega and Xu, 2006, Guest et al., 2013, Deng et al., 2015, Kanno et al., 
2015) and clinical studies (Saberi et al., 2008, Anderson et al., 2017) have been conducted to 
evaluate the safety and efficacy of Schwann cell transplantation for repair of injured spinal 
cord. After peripheral nerve injury Schwann cells dedifferentiate into non-myelinating 
Schwann cells and proliferate extensively. These newly formed non-myelinating Schwann 
cells migrate within the lesion and involved in nerve regeneration through expression of 
neurotrophic factors and neural cell adhesion molecules, recruitment of macrophages for 
removal of myelin debris as well as myelination or ensheathment of growing axons after 
differentiation into myelin-forming Schwann cells. A moderate improvement of motor function 
after Schwann cell transplantation was also concluded in a systematic review discussing the 
efficacy of Schwann cell transplantation for motor function recovery after spinal cord injuries 
in animal models (Hosseini et al., 2016). There is some evidence showing that spinal cord 
injuries and disruption of the glia limitations induce Schwan cells invasion within the CNS 
parenchyma and remyelination (Gilson and Stensaas, 1974, Matthews et al., 1979, Griffiths 
and McCulloch, 1983, Blight, 1985, Franklin and Blakemore, 1993, Bartholdi and Schwab, 
1998, Salgado-Ceballos et al., 1998, Hui et al., 2010, James et al., 2011). Besides of cell 
migration evidence, considerable proliferation of Schwann cells in the lesion confirm the 
participation of these cells in axon ensheathment/remyelination after TSCI.
Schwann cells mostly contributed in ensheathment/remyelination of axons in the dorsal 
column. Although in the most studies this observation has been attributed to the route of 
peripheral Schwann cells invasion, one recent study through a comprehensive evaluation of the 
fate of OPCs showed that CNS OPCs are the main origin of remyelinating Schwann cells in 
the dorsal column (Assinck et al., 2017). Axon ensheathment/remyelination by Schwann cells 
continued to one year pi. 
In conclusion, the cumulative evidence shows that in animal models, the number of 
oligodendrocytes approaches to the normal levels after about one month pi. The majority of 
oligodendrocytes are lost at the epicentre and adjacent regions, however, OPCs proliferation 
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and subsequent differentiation to myelinating cells (both oligodendrocytes and Schwann cells) 
are the main route to compensate the extensive demyelination after injury. Invading peripheral 
Schwann cells also contribute in remyelination. Therefore, pharmacotherapy for enhancing 
OPCs proliferation and differentiation to mature myelinating cells (oligodendrocytes or 
Schwann cells) can be the therapeutic target (Imamura et al., 2015) and the evidence-based 
trends obtained for oligodendrocyte apoptosis, proliferation and differentiation can be used as 
a guide to design preclinical and in the next step clinical studies. 
Limitations of the work:
Although the evidence shows that oligodendrogliogenesis and axon 
ensheathment/remyelination after TSCI is a continual process by the chronic phase, we do not 
yet know whether the newly myelinated axons are functional, since mature oligodendrocyte 
can remyelinate even dead axons or artificial fibers (Lee et al., 2012, Lee et al., 2013). 
Therefore, the functional benefit of the new formed myelin remains to be clear. 
CONFLICT OF INTREST STATEMENT
The authors have no conflicts of interest.
AUTHOR CONTRIBUTIONS
All authors passed four criteria for authorship contribution based on recommendations of the 
International Committee of Medical Journal Editors.
ACKNOWLEDGMENT
This study was supported by Sina Trauma and Surgery Research Center, Tehran University of 
Medical Sciences, Tehran, Iran (No. 38-40786).
REFERENCES
Abe Y, Yamamoto T, Sugiyama Y, Watanabe T, Saito N, Kayama H, Kumagai T (1999) 
Apoptotic cells associated with Wallerian degeneration after experimental spinal cord 
injury: a possible mechanism of oligodendroglial death. Journal of neurotrauma 
16:945-952.
  
19
Anderson KD, Guest JD, Dietrich WD, Bartlett Bunge M, Curiel R, Dididze M, Green BA, 
Khan A, Pearse DD, Saraf-Lavi E, Widerstrom-Noga E, Wood P, Levi AD (2017) 
Safety of Autologous Human Schwann Cell Transplantation in Subacute Thoracic 
Spinal Cord Injury. Journal of neurotrauma 34:2950-2963.
Assinck P, Duncan GJ, Plemel JR, Lee MJ, Stratton JA, Manesh SB, Liu J, Ramer LM, Kang 
SH, Bergles DE, Biernaskie J, Tetzlaff W (2017) Myelinogenic Plasticity of 
Oligodendrocyte Precursor Cells following Spinal Cord Contusion Injury. The Journal 
of neuroscience : the official journal of the Society for Neuroscience 37:8635-8654.
Barnabe-Heider F, Goritz C, Sabelstrom H, Takebayashi H, Pfrieger FW, Meletis K, Frisen J 
(2010) Origin of new glial cells in intact and injured adult spinal cord. Cell stem cell 
7:470-482.
Bartholdi D, Schwab ME (1998) Oligodendroglial reaction following spinal cord injury in rat: 
transient upregulation of MBP mRNA. Glia 23:278-284.
Blight AR (1985) Delayed demyelination and macrophage invasion: a candidate for secondary 
cell damage in spinal cord injury. Central nervous system trauma : journal of the 
American Paralysis Association 2:299-315.
Brook GA, Plate D, Franzen R, Martin D, Moonen G, Schoenen J, Schmitt AB, Noth J, 
Nacimiento W (1998) Spontaneous longitudinally orientated axonal regeneration is 
associated with the Schwann cell framework within the lesion site following spinal cord 
compression injury of the rat. Journal of neuroscience research 53:51-65.
Casha S, Yu WR, Fehlings MG (2001) Oligodendroglial apoptosis occurs along degenerating 
axons and is associated with FAS and p75 expression following spinal cord injury in 
the rat. Neuroscience 103:203-218.
Ceruti S, Villa G, Genovese T, Mazzon E, Longhi R, Rosa P, Bramanti P, Cuzzocrea S, 
Abbracchio MP (2009) The P2Y-like receptor GPR17 as a sensor of damage and a new 
potential target in spinal cord injury. Brain : a journal of neurology 132:2206-2218.
Crowe MJ, Bresnahan JC, Shuman SL, Masters JN, Crowe MS (1997) Apoptosis and delayed 
degeneration after spinal cord injury in rats and monkeys. Nature Medicine 3:73.
De Castro F, Bribian A, Ortega MC (2013) Regulation of oligodendrocyte precursor migration 
during development, in adulthood and in pathology. Cellular and molecular life 
sciences : CMLS 70:4355-4368.
Deng LX, Walker C, Xu XM (2015) Schwann cell transplantation and descending 
propriospinal regeneration after spinal cord injury. Brain Res 1619:104-114.
  
20
Dong H, Fazzaro A, Xiang C, Korsmeyer SJ, Jacquin MF, McDonald JW (2003) Enhanced 
oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with 
delayed Wallerian degeneration. The Journal of neuroscience : the official journal of 
the Society for Neuroscience 23:8682-8691.
Fehlings MG, Nakashima H, Nagoshi N, Chow DS, Grossman RG, Kopjar B (2016) Rationale, 
design and critical end points for the Riluzole in Acute Spinal Cord Injury Study 
(RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial. 
Spinal cord 54:8-15.
Franklin RJ, Blakemore WF (1993) Requirements for Schwann cell migration within CNS 
environments: a viewpoint. International journal of developmental neuroscience : the 
official journal of the International Society for Developmental Neuroscience 11:641-
649.
Frei E, Klusman I, Schnell L, Schwab ME (2000) Reactions of Oligodendrocytes to Spinal 
Cord Injury: Cell Survival and Myelin Repair. Experimental Neurology 163:373-380.
Fuhrmann T, Tam RY, Ballarin B, Coles B, Elliott Donaghue I, van der Kooy D, Nagy A, 
Tator CH, Morshead CM, Shoichet MS (2016) Injectable hydrogel promotes early 
survival of induced pluripotent stem cell-derived oligodendrocytes and attenuates 
longterm teratoma formation in a spinal cord injury model. Biomaterials 83:23-36.
Gautier HO, Evans KA, Volbracht K, James R, Sitnikov S, Lundgaard I, James F, Lao-Peregrin 
C, Reynolds R, Franklin RJ, Karadottir RT (2015) Neuronal activity regulates 
remyelination via glutamate signalling to oligodendrocyte progenitors. Nature 
communications 6:8518.
Gilson BC, Stensaas LJ (1974) Early axonal changes following lesions of the dorsal columns 
in rats. Cell and tissue research 149:1-20.
Griffiths IR, McCulloch MC (1983) Nerve fibres in spinal cord impact injuries. Part 1. Changes 
in the myelin sheath during the initial 5 weeks. J Neurol Sci 58:335-349.
Grossman SD, Rosenberg LJ, Wrathall JR (2001) Temporal-spatial pattern of acute neuronal 
and glial loss after spinal cord contusion. Exp Neurol 168:273-282.
Guest J, Santamaria AJ, Benavides FD (2013) Clinical translation of autologous Schwann cell 
transplantation for the treatment of spinal cord injury. Current opinion in organ 
transplantation 18:682-689.
Hassannejad Z, Sharif-Alhoseini M, Shakouri-Motlagh A, Vahedi F, Zadegan SA, Mokhatab 
M, Rezvan M, Saadat S, Shokraneh F, Rahimi-Movaghar V (2016) Potential variables 
  
21
affecting the quality of animal studies regarding pathophysiology of traumatic spinal 
cord injuries. Spinal cord 54:579-583.
Hassannejad Z, Zadegan SA, Shakouri-Motlagh A, Mokhatab M, Rezvan M, Sharif-Alhoseini 
M, Shokraneh F, Moshayedi P, Rahimi-Movaghar V (2018) The fate of neurons after 
traumatic spinal cord injury in rats: A systematic review. Iranian journal of basic 
medical sciences 21:546-557.
Hesp ZC, Goldstein EZ, Miranda CJ, Kaspar BK, McTigue DM (2015) Chronic 
oligodendrogenesis and remyelination after spinal cord injury in mice and rats. The 
Journal of neuroscience : the official journal of the Society for Neuroscience 35:1274-
1290.
Hill CE, Beattie MS, Bresnahan JC (2001) Degeneration and sprouting of identified descending 
supraspinal axons after contusive spinal cord injury in the rat. Exp Neurol 171:153-169.
Horky LL, Galimi F, Gage FH, Horner PJ (2006) Fate of endogenous stem/progenitor cells 
following spinal cord injury. The Journal of comparative neurology 498:525-538.
Hosseini M, Yousefifard M, Baikpour M, Rahimi-Movaghar V, Nasirinezhad F, Younesian S, 
Safari S, Ghelichkhani P, Moghadas Jafari A (2016) The efficacy of Schwann cell 
transplantation on motor function recovery after spinal cord injuries in animal models: 
A systematic review and meta-analysis. J Chem Neuroanat 78:102-111.
Houle JD, Jin Y (2001) Chronically injured supraspinal neurons exhibit only modest axonal 
dieback in response to a cervical hemisection lesion. Exp Neurol 169:208-217.
Huang SQ, Tang CL, Sun SQ, Yang C, Xu J, Wang KJ, Lu WT, Huang J, Zhuo F, Qiu GP, Wu 
XY, Qi W (2014) Demyelination initiated by oligodendrocyte apoptosis through 
enhancing endoplasmic reticulum-mitochondria interactions and Id2 expression after 
compressed spinal cord injury in rats. CNS neuroscience & therapeutics 20:20-31.
Hui SP, Dutta A, Ghosh S (2010) Cellular response after crush injury in adult zebrafish spinal 
cord. Developmental dynamics : an official publication of the American Association of 
Anatomists 239:2962-2979.
Imamura O, Arai M, Dateki M, Ogata T, Uchida R, Tomoda H, Takishima K (2015) Nicotinic 
acetylcholine receptors mediate donepezil-induced oligodendrocyte differentiation. 
Journal of neurochemistry 135:1086-1098.
James ND, Bartus K, Grist J, Bennett DL, McMahon SB, Bradbury EJ (2011) Conduction 
failure following spinal cord injury: functional and anatomical changes from acute to 
chronic stages. The Journal of neuroscience : the official journal of the Society for 
Neuroscience 31:18543-18555.
  
22
Jazayeri SB, Beygi S, Shokraneh F, Hagen EM, Rahimi-Movaghar V (2015) Incidence of 
traumatic spinal cord injury worldwide: a systematic review. European spine journal : 
official publication of the European Spine Society, the European Spinal Deformity 
Society, and the European Section of the Cervical Spine Research Society 24:905-918.
Kanno H, Pearse DD, Ozawa H, Itoi E, Bunge MB (2015) Schwann cell transplantation for 
spinal cord injury repair: its significant therapeutic potential and prospectus. Reviews 
in the neurosciences 26:121-128.
Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K, Steward O (2005) Human 
embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate 
and restore locomotion after spinal cord injury. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 25:4694-4705.
Lee S, Chong SYC, Tuck SJ, Corey JM, Chan JR (2013) A rapid and reproducible assay for 
modeling myelination by oligodendrocytes using engineered nanofibers. Nature 
Protocols 8:771.
Lee S, Leach MK, Redmond SA, Chong SY, Mellon SH, Tuck SJ, Feng ZQ, Corey JM, Chan 
JR (2012) A culture system to study oligodendrocyte myelination processes using 
engineered nanofibers. Nature methods 9:917-922.
Li GL, Farooque M, Holtz A, Olsson Y (1999) Apoptosis of oligodendrocytes occurs for long 
distances away from the primary injury after compression trauma to rat spinal cord. 
Acta neuropathologica 98:473-480.
Lytle JM, Wrathall JR (2007) Glial cell loss, proliferation and replacement in the contused 
murine spinal cord. The European journal of neuroscience 25:1711-1724.
Martin D, Robe P, Franzen R, Delree P, Schoenen J, Stevenaert A, Moonen G (1996) Effects 
of Schwann cell transplantation in a contusion model of rat spinal cord injury. Journal 
of neuroscience research 45:588-597.
Matthews MA, St Onge MF, Faciane CL, Gelderd JB (1979) Axon sprouting into segments of 
rat spinal cord adjacent to the site of a previous transection. Neuropathology and 
applied neurobiology 5:181-196.
McDonough A, Hoang AN, Monterrubio AM, Greenhalgh S, Martinez-Cerdeno V (2013) 
Compression injury in the mouse spinal cord elicits a specific proliferative response 
and distinct cell fate acquisition along rostro-caudal and dorso-ventral axes. 
Neuroscience 254:1-17.
  
23
McTigue DM, Wei P, Stokes BT (2001) Proliferation of NG2-positive cells and altered 
oligodendrocyte numbers in the contused rat spinal cord. The Journal of neuroscience 
: the official journal of the Society for Neuroscience 21:3392-3400.
Nagoshi N, Nakashima H, Fehlings MG (2015) Riluzole as a neuroprotective drug for spinal 
cord injury: from bench to bedside. Molecules (Basel, Switzerland) 20:7775-7789.
Oudega M, Xu XM (2006) Schwann cell transplantation for repair of the adult spinal cord. 
Journal of neurotrauma 23:453-467.
Piantino J, Burdick JA, Goldberg D, Langer R, Benowitz LI (2006) An injectable, 
biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and 
improves performance after spinal cord injury. Experimental Neurology 201:359-367.
Priest CA, Manley NC, Denham J, Wirth ED, Lebkowski JS (2015) Preclinical safety of human 
embryonic stem cell-derived oligodendrocyte progenitors supporting clinical trials in 
spinal cord injury. Regenerative medicine 10:939-958.
Rabchevsky AG, Sullivan PG, Scheff SW (2007) Temporal-spatial dynamics in 
oligodendrocyte and glial progenitor cell numbers throughout ventrolateral white 
matter following contusion spinal cord injury. Glia 55:831-843.
Rowland JW, Hawryluk GW, Kwon B, Fehlings MG (2008) Current status of acute spinal cord 
injury pathophysiology and emerging therapies: promise on the horizon. Neurosurgical 
focus 25:E2.
Saberi H, Moshayedi P, Aghayan HR, Arjmand B, Hosseini SK, Emami-Razavi SH, Rahimi-
Movaghar V, Raza M, Firouzi M (2008) Treatment of chronic thoracic spinal cord 
injury patients with autologous Schwann cell transplantation: an interim report on 
safety considerations and possible outcomes. Neurosci Lett 443:46-50.
Salgado-Ceballos H, Gabriel G-S, Alfredo F-V, Israel G, Laura E, Antonio I, Ignacio M (1998) 
Spontaneous long-term remyelination after traumatic spinal cord injury in rats. Brain 
Research 782:126-135.
Sellers DL, Maris DO, Horner PJ (2009) Postinjury niches induce temporal shifts in progenitor 
fates to direct lesion repair after spinal cord injury. The Journal of neuroscience : the 
official journal of the Society for Neuroscience 29:6722-6733.
Shuman SL, Bresnahan JC, Beattie MS (1997) Apoptosis of microglia and oligodendrocytes 
after spinal cord contusion in rats. Journal of neuroscience research 50:798-808.
Tripathi R, McTigue DM (2007) Prominent oligodendrocyte genesis along the border of spinal 
contusion lesions. Glia 55:698-711.
  
24
van Tilborg E, de Theije CGM, van Hal M, Wagenaar N, de Vries LS, Benders MJ, Rowitch 
DH, Nijboer CH (2018) Origin and dynamics of oligodendrocytes in the developing 
brain: Implications for perinatal white matter injury. Glia 66:221-238.
Vick RS, Neuberger TJ, DeVries GH (1992) Role of adult oligodendrocytes in remyelination 
after neural injury. Journal of neurotrauma 9 Suppl 1:S93-103.
Wang L, Hu B, Wong WM, Lu P, Wu W, Xu XM (2009) Glial and axonal responses in areas 
of Wallerian degeneration of the corticospinal and dorsal ascending tracts after spinal 
cord dorsal funiculotomy. Neuropathology : official journal of the Japanese Society of 
Neuropathology 29:230-241.
Warden P, Bamber NI, Li H, Esposito A, Ahmad KA, Hsu CY, Xu XM (2001) Delayed glial 
cell death following wallerian degeneration in white matter tracts after spinal cord 
dorsal column cordotomy in adult rats. Exp Neurol 168:213-224.
Wu D, Shibuya S, Miyamoto O, Itano T, Yamamoto T (2005) Increase of NG2-positive cells 
associated with radial glia following traumatic spinal cord injury in adult rats. Journal 
of neurocytology 34:459-469.
Yang H, Lu P, McKay HM, Bernot T, Keirstead H, Steward O, Gage FH, Edgerton VR, 
Tuszynski MH (2006) Endogenous neurogenesis replaces oligodendrocytes and 
astrocytes after primate spinal cord injury. The Journal of neuroscience : the official 
journal of the Society for Neuroscience 26:2157-2166.
Yong C, Arnold PM, Zoubine MN, Citron BA, Watanabe I, Berman NE, Festoff BW (1998) 
Apoptosis in cellular compartments of rat spinal cord after severe contusion injury. 
Journal of neurotrauma 15:459-472.
Zai LJ, Wrathall JR (2005) Cell proliferation and replacement following contusive spinal cord 
injury. Glia 50:247-257.
FIGURE LEGENDS AND TABLES
Fig. 1. PRISMA Flow diagram
Fig. 2. Evidence-based representation of temporal and spatial progress of oligodendrocytes 
apoptotic death after traumatic spinal cord injuries (TSCI): The extent of cell death is showed 
at the epicenter and the areas adjacent to the epicenter (i.e. 1-14 mm). The first sign of apoptotic 
death was observed at the epicentre at 6-24 hours post-injury. At day 3-7 the maximum number 
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of apoptotic oligodendrocytes was detected at the epicentre. After this time point, the majority 
of oligodendrocytes are dead (no results were reported at the epicentre after day 7: dash line as 
the hypothetic cell death trend). On the other hand, in the areas adjacent to the epicenter (distal), 
oligodendrocytes apoptosis was maximized at around 7 days post-injury. All the related data 
regardless of the method and reporting format are compiled in this schematic figure.
Fig. 3. Temporal proliferative response of oligodendrocyte progenitor cells (OPCs) in response 
to TSCI: Proliferation rate at the epicentre decreases within a few days after injury compared 
to normal animals in which a constant low proliferation rate of progenitor cells is observed 
(horizontal dash line). However, the proliferation rate reached to a maximum in the epicenter 
at one week post-injury. At the lesion border and distal area, the proliferation of OPCs increases 
and peaks within 1-2 weeks post-injury, followed by a decrease to approach normal levels by 
the 10th week.
Fig. 4. Evidence-based temporal representation of the total number of mature 
oligodendrocytes: The total number of oligodendrocytes decreases dramatically due to 
extensive cell loss during the first week pi. At day 7, the earliest evidence of MBP mRNA was 
reported at the lesion borders which indicates a trigger for remyeliantion. During the second 
week, more progenitor cells are formed contributing to the subsequent increase in the number 
of mature oligodendrocytes. Oligodendrogliogenesis, i.e. increase in the number of newly 
formed mature oligodendrocytes, is followed by proliferation of progenitor cells from the 
second week onward until the total number of oligodendrocytes reaches to the number of cells 
in normal controls (dash line).
Fig. 5. Axon demyelination and remyelination after traumatic spinal cord injury (TSCI): (A) 
in the normal adult CNS tissue myelin sheath is produced by oligodendrocyte and each cell 
forms one segment of myelin for several adjacent axons. (B) TSCI results in extensive 
oligodendrocyte death and subsequently axon demyelination. Survived oligodendrocytes are 
post-mitotic and their contribution in remyelination is negligible. (C) However, increased 
proliferation and recruitment of oligodendrocyte progenitor cells (OPCs) and their 
differentiation to the mature myelinating oligodendrocytes at the injury site compensate the 
lack of myelin forming cells. (D) Schwann cells originated from peripheral nervous system or 
differentiated from OPCs are another contributing cells for myelin formation after TSCI. 
Myelin sheath formed by Schwann cells have thicker thickness and mainly contains P0, 
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peripheral myelin protein 22 kD (PMP22) and myelin basic protein (MBP). Also, each 
Schwann cell can wrap only on axon. However, myelin produced by oligodendrocytes has 
thinner thickness and contains myelin proteolipid protein (PLP), 2',3'-Cyclic nucleotide 3'-
phosphohydrolase (CNPase), receptor interacting protein (RIP) and myelin basic protein 
(MBP).
Table 1 Characteristics of included studies
Table 2 Quality assessment of included studies
Table 3 Summary of the markers and methods used to identify the cell types (i.e., 
oligodendrocytes and oligodendrocyte progenitor cells) and to detect apoptosis
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Table 1 Characteristics of the included studies
First 
author, 
Year
Sample 
Size
(T/Inj./ 
Cont.)1
Gender/ 
Species/ 
Weight (g) or 
Age
Method/ 
Level of 
Injury
Severity of 
Injury
Method of 
Evaluation
Time 
(post-
injury)3
1 Abe 1999 N2/N/N M/ Wistar 
rat/4 W
Complete 
transection 
T11
 razor blade Immunohistoc
hemistry, 
TUNEL
3, 5, 7, 
14D
2 Assinck 
2017
233/at least 
3/2
M&F/ CreER 
transgenic 
mice
Contusion
T9-10 
Infinite 
Horizons 
Impactor, 70 
kdyne
FACS, BrdU, 
Immunohistoc
hemistry
3, 12 W
3 Barnabe-
Heider 
2010
54/9/N M&F /FoxJ1-
CreER, Cx30-
CreER and 
Olig2-CreER 
mice/2-8.5 M
Transection
T4,T10 
Dorsal 
funiculus was 
cut 
transversely 
without 
reaching the 
gray matter
Immunohistoc
hemistry, 
TUNEL, BrdU
14 D, 4 
M
4 Bartholdi 
1998
36/at least 
2/1
N/Lewis rat/8 
W
Hemisection
T10
2/3 of spinal 
cord depth
Immunohistoc
hemistry
6, 24 H, 
2, 4, 8, 
14 D
5 Blight 
1985
26/5/10 F/Mongrel 
cats/Adult
Compression
T9
A 13 g 
cylindrical 
brass weight 
was dropped 
by a pin in the 
Light and 
electron 
microscopy
2, 7 D, 
3, 8 M
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tube 20 cm 
above T9
6 Brook 
1998
24/at least 
3/N
M/Wistar rat/ 
200–250
Compression
 T11-T12
Balloon 
inflated with 
40 µl distilled 
water and left 
in place for 5 
minutes
Immunohistoc
hemistry
2, 7, 14, 
28 D
7 Casha 
2001
N/N/N F/Wistar 
rats/220-260
Compression
C7-T1
Moderately 
severe, Kerr 
Lougheed 
aneurysm clip, 
35 g closing 
force, clip 
compression
Immunohistoc
hemistry, 
TUNEL, 
Electron 
microscopy
1, 3, 7, 
14 D
8 Ceruti 
2009
N/5/N M/CD1 mice/ 
Adult 
Compression
T5-T8
Clip 
compression, 
closing force of 
24 g, 1 min 
Immunohistoc
hemistry, 
BrdU, 
Light 
microscopy, 
Haematoxylin 
eosin staining, 
luxol fast blue 
staining, 
Methyl green 
pyronin 
staining
24, 72 
H, 1 W
9 Dong 2003 27/at least 
6/N
N/ Mice/ 25–
30
Hemi-
transection
T9
Transection  on 
the right side 
only
Immunohistoc
hemistry, 
Electron 
microscopy
8, 30 D
10 Frei 2000 26/5/5 F/Lewis rat/2 
W
Contusion
T8
Moderate to 
severe injury  
contusion,  
NYU
Immunohistoc
hemistry
7 D
11 Gilson 
1974
51/N/N N/Lewis rat/ 
150
Hemi-
transection 
T1-T2 
Severe, razor,  
interrupted the 
dorsal 
columns, 
leaving the 
lateral funiculi 
intact
Light 
microscopy
1, 4, 
7,14 D
12 Griffiths 
1983
9/1/N N/Cat/N Contusion 
L2
100, 150, 200 
g/cm
light and 
electron
microscopy
1:30 H, 
1, 3, 21, 
42 D
13 Grossman 
2001
56/5/N F/SD4 rat/ 
200–250
Contusion
T8
Incomplete 
contusion,  
10g, 2.5cm
Electron 
microscopy, 
Immunohistoc
hemistry 
15 min, 
4 H, 8, 
1, 2 D
14 Hesp 2015 (Mice)
29/N/N
(Rats)
35/N/N
M&F/Mice/12 
weeks
F/SD rat/250 
Compression
T9 mouse 
T8 rat 
Moderate-
severe (75 
kDyne force; 
mouse),modera
te (150 kDyne 
force; rat) 
contusion 
injury Infinite 
Horizons 
device 
Immunocytoc
hemistry
0, 7, 14, 
28, 42, 
70 D
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(Precision 
Instruments)
15 Horky 
2006
344/5/5 F/Fisher 
rat/160-185
Hemisection 
T8
Hemi BrdU, 
Immunohistoc
hemistry
1D, 1 M
16 Huang 
2014
108/N/N N/SD rat/250-
320
Compression 
L1
Custom-made 
screw
Immunohistoc
hemistry, 
TUNEL 
1, 3, 7 D
17 Hui 2010  30/6/6 N/Zebrafish/ 
3–4 cm 
Compression
15–16th 
vertebrae 
1 S with a 
number-5 
Dumont 
forceps
BrdU,  
Transmission 
electron 
microscopy, 
Immunohistoc
hemistry
3, 7, 10, 
15 D, 1 
M
18 James 
2011
70/at least 
4/N
F/SD rat/ 
Adult
Compression
T10
Infinite 
Horizon 
impactor, 
moderate 
severe (159 
kDyn)
Immunohistoc
hemistry
1 D, 1, 
2, 4, 12 
W, 6 M
19 Li 1999 32/4/N M/Rat /370 Compression
T1, T5, T7, 
T8–9, T10, 
T12, L2
Compression,  
35-50 g, 5 min
Hematoxylin
and eosin,
Immunohistoc
hemistry,  
Luxol fast 
blue, TUNEL 
4, 9 D
20 Lytle  
2007
N/at least 
2/N
F/C57BL6 
mice/5-7 W
Contusion
T8-9
2g, 2.5cm
Mild
Immunohistoc
hemistry, 
BrdU
1, 3, 7, 
28D
21 Matthews 
1979
80/20/20 M/LE5 
rat/Adult 
Transection
T5
Strict aseptic 
technique 
Light and 
electron 
microscopy
15, 30 
90 D
22 McDonoug
h 2013
135/10/5 F/Swiss 
Webster 
mice/6-8 W
Compression
T10
Laterally 
compressed the 
spinal cord to a 
thickness of 
0.35 mm and 
held for 15 s 
using one pair 
of modified 
forceps
Immunocytoc
hemistry, 
BrdU, Nissl 
staining
 1, 2, 3, 
4, 6, 8, 
10, 12 
W
23 McTigue 
2001
N/at least 
4/N
F/Fischer/rat/1
70
Contusion
T8
Oohio state 
electromagneti
c spinal cord 
injury device 
(rapidly 
displace spinal 
tissue 1.1 mm 
f), moderate to 
severe
Immunohistoc
hemistry, 
BrdU
7, 14, 
28D
24 Rabchevsk
y 2007
N/6/6 F/SD rat/200–
225
Contusion 
T10
Moderate, 
NYU injury 
device
Immunohistoc
hemistry
2, 7, 14, 
42 D
25 Salgado-
Ceballos 
1998
28/at least 
3/N
F/LE rat/14-16 
W
Contusion
T9
weight-drop, 
severe
Electron 
microscopy
1, 2, 4, 
6, 12 M
26 Sellers 
2009
N/N/N N/Mice/8 W Hemisection
T9-10
cutting the 
dorsla spinal 
cord tissue 
until the central 
Immunohistoc
hemistry, 
Flow 
cytometry, 
1, 2 W
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canal could be 
visualized
27 Shuman 
1997
N/at least 
3/N
N/ Rat/ N Contusion 
T10
 NYU weight 
drop device, 
25g-cm
Immunohistoc
hemistry
8, 21 D
28 Tripathi 
2007
24/at least 
5/N
F/SD rat/225–
264
Contusion
T8
Moderate 
spinal 
contusions 
using the OSU 
injury
Electron 
microscopy, 
BrdU
1, 3, 4, 
7, 14 D
29 Wang 
2009
36/at least 
3/N
F/SD rat/230-
250
Transection
T8
microscissors 
transected both 
the dorsal 
ascending tract 
and 
corticospinal 
tract bilaterally
Electron 
microscopy, 
Immunocytoc
hemistry
10, 30 D
30 Warden 
2001
21/3/3 F/Fisher rat/ 
155-165
Transection
T7-8
Junction 
between T7-T8 
cord segments,  
microscissors 
lesion the 
dorsal funiculi 
and dorsal 
horns 
bilaterally
Immunohistoc
hemistry, 
TUNEL
4, 24 H, 
3, 7, 14, 
28 D
31 Wu 2005 N/5/5 M/SD rat/  
280-330
Contusion
T11-12
2mm 
weighting 30g 
was gentely 
placed on dura 
for 10 min
Immunohistoc
hemistry,  
NG2, GFAP, 
DAPI,  3CB2, 
GFAP
1 D, 1, 
4, 8, 12 
W
32 Yang 2006 5/1/1 M/Rhesus  
monkey/6–14 
Y
Hemi-section
C6-C7
Right-sided, 
30, 50, 65% 
hemi-section
Immunohistoc
hemistry, 
BrdU, 
Electron 
microscopy 
7 W and 
7 M
33 Yong 1998 N/N/N F/SD rat/300-
350
Contusion
T9-T10
Severe, weight-
drop method 
with the NYU 
impactor, using 
50.0 g/cm 
force
Immunohistoc
hemistry, 
TUNEL
1, 3, 7, 
14, 28 D
34 Zai 2005 40/at least 
4/N
F/SD rat/  
225–275
Contusion
T8
10g-2.5cm-
2.4mm
Immunohistoc
hemistry, 
BrdU 
3, 7, 42 
D
1 T: the number of total animals used in the study; Inj.: the number of injured animals in each experimental group; 
Cont.: the number of animals (i.e. normal, sham operated or laminectomy) in each control group
2 N: not specified 
3 S: second; Min: minute; H: hour; D: day; W: week; M: month; Y: year
4SD: Sprague-Dawley
5LE: Long-Evans
Table 2 Quality assessment of included studies
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First author and Year 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15
1 Abe 1999 + + + + + ? + ? + + ? ? ? ? +
2 Assinck 2017 + + + + + + + + + + + + + + ?
3 Barnabe-Heider 2010 + + + + + + + + + + ? ? + ? ?
4 Bartholdi 1998 + + + + + + + + + + + ? ? ? ?
5 Blight 1985 + + + + + + + + ? ? ? ? ? ? ?
6 Brook 1998 + + + + + + + ? + ? + ? ? ? ?
7 Casha 2001 + + + + + ? + ? ? + + ? + ? ?
8 Ceruti 2009 + + + + + + + + + ? + ? ? ? ?
9 Dong 2003 + + + + + + + + + ? ? ? ? ? ?
10 Frei 2000 + + + + + + + + + + ? ? ? ? ?
11 Gilson 1974 + + + + + ? ? ? ? ? ? ? ? ? ?
12 Griffiths 1983 + + + + + + + + + + + ? ? ? ?
13 Grossman 2001 + + + + + + + + + ? ? ? ? ? ?
14 Hesp 2015 + + + + + ? + ? + + + ? + ? ?
15 Horky 2006 + + + + + + + + + + + ? + ? ?
16 Huang 2014 + + ? + + ? + + + + ? ? ? + ?
17 Hui 2010 + + + + + + + + + ? - ? ? ? ?
18 James 2011 + + + + + + + + + + + ? ? ? ?
19 Li 1999 + + + + + + + ? + ? ? ? ? ? ?
20 Lytle 2007 + + + + + + + + + + + ? + ? ?
21 Matthews 1979 + + + + + + + + ? ? + ? ? ? ?
22 McDonough 2013 + + + + + + + + + + + ? + ? ?
23 McTigue 2001 + + + + + + + + + + ? ? ? ? +
24 Rabchevsky 2007 + + + + + + + + + + + ? + ? ?
25 Salgado-Ceballos 1998 + + + + + + ? + + + + ? ? ? ?
26 Sellers 2009 + + + + + ? + ? ? ? ? ? ? ? ?
27 Shuman 1997 + + + + + + + + + + ? ? ? ? ?
28 Tripathi 2007 + + + + + + + + + + + + ? ? +
29 Wang 2009 + + + + ? + + + + ? ? ? ? ? ?
30 Warden 2001 + + + + + + + + + ? + ? ? ? ?
31 Wu 2005 + + + + + + + ? ? + + ? ? ? ?
32 Yang 2006 + + + + + + + + + + ? ? ? ? ?
33 Yong 1998 + + + + + ? + ? + + + ? + ? +
34 Zai 2005 + + + + + + + + + ? ? ? ? ? ?
1. Species; 2. Using appropriate tests; 3. Severity of injury; 4. Level of injury; 5. Age/weight; 6. Number of 
injured animals per group; 7. Designation of strain; 8. Definition of control (normal, sham operated or 
laminectomy); 9. Description of statistical analysis; 10. Regulation and ethics; 11. Bladder expression; 12. 
Blindness of assessor; 13. Genetic background; 14. Method of allocation to treatments; 15. Description of the 
reasons to exclude animals from the experiment during the study (attrition), where + means clearly specified, 
? has not specified clearly, and – specified as it has not been considered in the study.
Table 3 List of the markers and methods used to identify the cell types (i.e., oligodendrocytes 
and OPCs1) and to detect apoptosis
Cell types/Assessment type Markers/ Method of Assessment
Mature oligodendrocytes CC1(anti-APC 2)
CNPase 3
PLP 4
MBP 5
RIP 6
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OPCs Olig2
NG2 7
PDGFRα 8
Proliferation assay BrdU (Bromodeoxyyuridine)
Apoptosis assay TUNEL (Terminal deoxynucleotidyl transferase (TdT) 
dUTP Nick-End Labeling)
Caspase-3 expression
1 Oligodendrocyte Progenitor Cells
2 Anti‐Adenomatous Polyposis Coli
3 2',3'-Cyclic nucleotide 3'-phosphohydrolase
4 Myelin Proteolipid Protein
5 Myelin Basic Protein
6 Receptor Interacting Protein
7 Neuron-Glial Antigen 2
8 platelet-Derived Growth Factor Receptor-alpha
Highlights 
 Extensive oligodendrocyte death during the first two weeks after TSCI leave a broad 
number of denuded axons 
 OPCs start proliferation at the lesion borders and spared tissues as early as one day after 
injury
 Within the first two weeks after injury the proliferation rate of OPCs reaches to a 
maximum 
 Differentiation of newly formed OPCs compensate the lack of oligodendrocytes
 OPC-derived Schwann cells as well as invading peripheral Schwann cells also 
contribute in remyelination after TSCI
